Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Pancreatic Ductal Adenocarcinoma”

265 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 265 results

Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Study completedNCT01897415
What this trial is testing

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Who this might be right for
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
University of Pennsylvania 16
Testing effectiveness (Phase 2)Ended earlyNCT05114213
What this trial is testing

MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

Who this might be right for
Pancreatic Cancer
Ludwig-Maximilians - University of Munich 9
Early research (Phase 1)Looking for participantsNCT05685602
What this trial is testing

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 43
Early research (Phase 1)WithdrawnNCT04799431
What this trial is testing

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Cancer MetastaticColorectal Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableNot Yet RecruitingNCT07014254
What this trial is testing

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Adenocarcinoma of the StomachColorectal Cancer Metastatic+1 more
Xijing Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Large-scale testing (Phase 3)Looking for participantsNCT05254171
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
Panbela Therapeutics, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT02981342
What this trial is testing

Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Eli Lilly and Company 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT04999969
What this trial is testing

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
AstraZeneca 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT05915351
What this trial is testing

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas AdenocarcinomaPancreas Cancer
University of Kansas Medical Center 28
Early research (Phase 1)Not Yet RecruitingNCT07348107
What this trial is testing

ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Daniel Breadner 10
Early research (Phase 1)Study completedNCT02501902
What this trial is testing

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 76
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 520
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableLooking for participantsNCT05346536
What this trial is testing

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerCirculating Tumor Cell
University Hospital, Montpellier 63
Testing effectiveness (Phase 2)Study completedNCT03415854
What this trial is testing

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma+2 more
HonorHealth Research Institute 11
Not applicableLooking for participantsNCT05475366
What this trial is testing

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)

Who this might be right for
Carcinoma, Pancreatic DuctalPrognosis
Institut Curie 62
Load More Results